NCT07614763Completed
To Study and Explore the Predictive Effect of Insulin Resistance-related Indicators on In-stent Restenosis After Coronary Stent Implantation
The Predictive Effect of Insulin Resistance Metabolic Score on In-stent Restenosis After Coronary Stent Implantation
Source: ClinicalTrials.gov · Last updated 29 May 2026
Brief summary (registry, in English)
Based on previous studies on insulin resistance and cardiovascular diseases, we believe that the insulin resistance metabolic score also has certain predictive value for the prognosis of in-stent restenosis after coronary stent implantation. The main purpose of this study is to explore the predictive effect of the insulin resistance metabolic score on in-stent restenosis after coronary stent implantation and to discuss a reasonable control level.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 1000 (actual)
- First submitted
- 6 Feb 2026
- Start date
- 1 Jan 2022
- Primary completion date
- 1 Nov 2025
- Lead sponsor
- Qilu Hospital of Shandong University
- Diseases
- Coronary artery disease
- NCT number
- NCT07614763
What you commit to
- Study type: Observational
- Participants enrolled: 1000
- From 1 Jan 2022 to the primary completion date, 1 Nov 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Previous coronary artery bypass grafting
Other illness
- Clinical manifestations of heart failure, structural cardiomyopathy, congenital heart disease, or significant valvular heart disease
Other
- Lesions treated only with balloon angioplasty without stent implantation
- Severe hepatic or renal dysfunction, such as estimated glomerular filtration rate \<30 mL/min/1.73 m²
- Incomplete clinical or angiographic data
Who the study is looking for
- Age ≥45 years
- Patients with a history of percutaneous coronary intervention (PCI) with stent implantation
- Patients who underwent repeat coronary angiography during follow-up
- Complete clinical data available, including echocardiography, 24-hour ambulatory electrocardiogram, NT-proBNP, liver and kidney function tests, and blood biochemical tests
Age in the registry: 45 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Qilu Hospital of Shandong University Coordinator of this site? Confirm its status | Jinan | China | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.